NO20072255L - Sammensetning omfattende acetaminofen, koffein og valgfritt aspirin sammen med et alkalisk middel for forbedret absorpsjon - Google Patents

Sammensetning omfattende acetaminofen, koffein og valgfritt aspirin sammen med et alkalisk middel for forbedret absorpsjon

Info

Publication number: NO20072255L
Authority: NO; Norway
Prior art keywords: composition; acetaminophen; caffeine; optional; alkaline agent
Prior art date: 2004-10-28

Application number

NO20072255A

Other languages

English (en)

Norwegian (no)

Inventor

Rong Liu

Michael Corbo

Jatin Desai

Gerard P Frunzi

Xiaohong Qi

Candice Y Choi

Rahul R Gandhi

Atef Z Boulos

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-28

Filing date

2007-05-02

Publication date

2007-07-18

2007-05-02 Application filed by Novartis Ag filed Critical Novartis Ag

2007-07-18 Publication of NO20072255L publication Critical patent/NO20072255L/no

Links

239000000203 mixture Substances 0.000 title abstract 7
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 4
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title abstract 4
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 2
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 title abstract 2
229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
229960001948 caffeine Drugs 0.000 title abstract 2
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 title abstract 2
229960005489 paracetamol Drugs 0.000 title abstract 2
238000010521 absorption reaction Methods 0.000 title 1
230000000202 analgesic effect Effects 0.000 abstract 4
230000001754 anti-pyretic effect Effects 0.000 abstract 3
239000002221 antipyretic Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000004904 shortening Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20072255A 2004-10-28 2007-05-02 Sammensetning omfattende acetaminofen, koffein og valgfritt aspirin sammen med et alkalisk middel for forbedret absorpsjon NO20072255L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62281204P	2004-10-28	2004-10-28
PCT/US2005/038507 WO2006049978A1 (en)	2004-10-28	2005-10-26	Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption

Publications (1)

Publication Number	Publication Date
NO20072255L true NO20072255L (no)	2007-07-18

Family

ID=35744599

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20072255A NO20072255L (no)	2004-10-28	2007-05-02	Sammensetning omfattende acetaminofen, koffein og valgfritt aspirin sammen med et alkalisk middel for forbedret absorpsjon

Country Status (17)

Country	Link
US (1)	US20070298096A1 (de)
EP (1)	EP1807068B1 (de)
JP (1)	JP2008518914A (de)
CN (1)	CN101048155A (de)
AR (1)	AR051145A1 (de)
AT (1)	ATE460930T1 (de)
AU (1)	AU2005302618B2 (de)
BR (1)	BRPI0520000A2 (de)
CA (1)	CA2583517C (de)
DE (1)	DE602005020048D1 (de)
MX (1)	MX2007005121A (de)
NO (1)	NO20072255L (de)
PE (1)	PE20061125A1 (de)
PL (1)	PL1807068T3 (de)
PT (1)	PT1807068E (de)
RU (1)	RU2398571C2 (de)
WO (1)	WO2006049978A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0607085D0 (en)	2006-04-07	2006-05-17	Smithkline Beecham Corp	Novel compositions
CN100417385C (zh) *	2006-09-26	2008-09-10	林星	一种用于治疗外伤的外用制剂
GB0707489D0 (en) *	2007-04-18	2007-05-23	Renaissance Pharma	Compounds
CN101596163B (zh) *	2008-06-06	2012-06-27	康美保宁（四川）制药有限公司	阿咖酚微丸制剂及其制备方法
GB0813929D0 (en) *	2008-07-30	2008-09-03	Glaxo Group Ltd	Novel method
CN102861040B (zh) *	2012-08-02	2014-04-23	广东环球制药有限公司	含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法
CN102949401A (zh) *	2012-09-06	2013-03-06	广东九明制药有限公司	对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺
US10124005B1 (en) *	2017-12-15	2018-11-13	Lisa Josette Myslinski	Multisymptom migraine combination medication
CN110711197B (zh) *	2018-07-12	2023-11-24	北京恒润泰生医药科技有限公司	阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用
CN108853124A (zh) *	2018-08-15	2018-11-23	康美保宁（四川）制药有限公司	一种阿咖酚制剂及其制剂方法
GB202007670D0 (en) *	2020-05-22	2020-07-08	Glaxosmithkline Consumer Healthcare Holdings Us Llc	Pharmaceutical composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4294819A (en) *	1980-08-18	1981-10-13	Bristol-Myers Company	Alkaline analgesic capsule
CA1182049A (en) *	1981-07-13	1985-02-05	Francis J. Sterbenz	Apap antacid composition
US5296241A (en) *	1991-04-03	1994-03-22	Brimberg Barnett J	Therapeutic composition and method of using same for treatment of hangover
JP3122748B2 (ja) *	1991-11-29	2001-01-09	ライオン株式会社	イブプロフェン含有解熱鎮痛剤
JP3172749B2 (ja) *	1992-02-17	2001-06-04	ライオン株式会社	イブプロフェン含有製剤
JPH06227995A (ja) *	1993-02-03	1994-08-16	Takeda Chem Ind Ltd	安定化された固型製剤
JPH07206689A (ja) *	1994-01-21	1995-08-08	Barnett Lab Ltd	治療組成物および宿酔の治療のためのこの組成物の使用法
DE19502789A1 (de) *	1995-01-28	1996-08-01	Dirk Krischenowski	Arzneimittel
RU2101014C1 (ru) *	1995-09-07	1998-01-10	Акционерное общество "Курский комбинат лекарственных средств"	Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
GB9704524D0 (en) *	1997-03-05	1997-04-23	Smithkline Beecham Plc	Composition
US5972916A (en) *	1997-07-14	1999-10-26	Bristol-Myers Squibb Company	Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) *	2000-06-28	2002-01-15	Lion Corp	内服薬組成物
US20040147606A1 (en) *	2001-05-25	2004-07-29	Yoichi Onuki	Medicinal compositions
JP4553552B2 (ja) *	2003-01-08	2010-09-29	日東薬品工業株式会社	生体リズム応用キット

2005
- 2005-10-26 AU AU2005302618A patent/AU2005302618B2/en not_active Expired
- 2005-10-26 MX MX2007005121A patent/MX2007005121A/es active IP Right Grant
- 2005-10-26 JP JP2007539060A patent/JP2008518914A/ja active Pending
- 2005-10-26 EP EP05821186A patent/EP1807068B1/de not_active Expired - Lifetime
- 2005-10-26 WO PCT/US2005/038507 patent/WO2006049978A1/en not_active Ceased
- 2005-10-26 AR ARP050104491A patent/AR051145A1/es not_active Application Discontinuation
- 2005-10-26 DE DE602005020048T patent/DE602005020048D1/de not_active Expired - Lifetime
- 2005-10-26 CN CNA2005800370243A patent/CN101048155A/zh active Pending
- 2005-10-26 PE PE2005001253A patent/PE20061125A1/es not_active Application Discontinuation
- 2005-10-26 RU RU2007119641/15A patent/RU2398571C2/ru not_active IP Right Cessation
- 2005-10-26 CA CA2583517A patent/CA2583517C/en not_active Expired - Fee Related
- 2005-10-26 US US11/666,528 patent/US20070298096A1/en not_active Abandoned
- 2005-10-26 PL PL05821186T patent/PL1807068T3/pl unknown
- 2005-10-26 BR BRPI0520000-8A patent/BRPI0520000A2/pt not_active IP Right Cessation
- 2005-10-26 AT AT05821186T patent/ATE460930T1/de not_active IP Right Cessation
- 2005-10-26 PT PT05821186T patent/PT1807068E/pt unknown
2007
- 2007-05-02 NO NO20072255A patent/NO20072255L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR051145A1 (es)	2006-12-20
PT1807068E (pt)	2010-04-19
US20070298096A1 (en)	2007-12-27
EP1807068B1 (de)	2010-03-17
BRPI0520000A2 (pt)	2009-04-07
PE20061125A1 (es)	2006-11-08
AU2005302618A1 (en)	2006-05-11
RU2007119641A (ru)	2008-12-10
RU2398571C2 (ru)	2010-09-10
EP1807068A1 (de)	2007-07-18
ATE460930T1 (de)	2010-04-15
WO2006049978A1 (en)	2006-05-11
MX2007005121A (es)	2007-06-22
CA2583517A1 (en)	2006-05-11
AU2005302618B2 (en)	2009-10-22
CA2583517C (en)	2013-06-04
CN101048155A (zh)	2007-10-03
PL1807068T3 (pl)	2010-08-31
DE602005020048D1 (de)	2010-04-29
JP2008518914A (ja)	2008-06-05

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK2029529T3 (da)	2010-09-20	Substitueret pyrrolidinone som inhibitor af 11-beta-hydroxysteroiddehydrogenase 1
NO20060416L (no)	2006-03-24	Ny anvendelse I
NO20025601D0 (no)	2002-11-21	Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
EA200801826A1 (ru)	2009-02-27	Дейтерированные производные катехоламина и лекарственные средства, содержащие указанные соединения
EA200970296A1 (ru)	2009-10-30	Содержащие диариловый эфир соединения мочевины
DK2049513T3 (da)	2012-02-27	Piperidinylsubstituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
AR049083A1 (es)	2006-06-28	Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
NO20074509L (no)	2007-11-12	Kombinasjon av organiske forbindelser
EA200870462A1 (ru)	2009-04-28	Производные бифениламидлактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
EA200702498A1 (ru)	2008-06-30	N-(пиридин-2-ил)сульфонамидные производные
DK2035379T3 (da)	2010-09-06	Inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
EP1391201A4 (de)	2004-06-30	Medizinische zusammensetzungen
SE0301886D0 (sv)	2003-06-25	New use V
EA200700118A1 (ru)	2007-08-31	Амидосоединения и их применение в качестве лекарственных средств
NO20075361L (no)	2007-12-20	Fremgangsmate og preparat for behandling av slimhinneforstyrrelser
NO20071742L (no)	2007-04-02	Kinazoliner som er nyttige som modulatorer av ionekanaler
EA200870460A1 (ru)	2009-04-28	Производные циклогексилпиразол-лактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
DK1225881T3 (da)	2006-06-12	Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion
CL2007000345A1 (es)	2008-01-11	Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de uno o mas agentes terapeuticos y una cantidad mejoradora de la absorcion intestinal de uno o mas agonistas de receptores de zonulina/zot; y uso de la composicion para tratar la diabetes.
EA200701845A1 (ru)	2008-02-28	Рофлумиласт для лечения сахарного диабета
CR6824A (es)	2008-11-25	Derivados de arilmetilamina para uso como inhibidores de triptasa
BRPI0510842A (pt)	2007-11-27	composição e seu uso
ES2487496T3 (es)	2014-08-21	Agente para aliviar el síndrome metabólico
ATE468098T1 (de)	2010-06-15	Topische stabilisierte dosierungsformen für prostaglandin e-verbindungen
MX2007005121A (es)	2007-06-22	Composicion que comprende acetaminofen, cafeina y opcionalmente aspirina junto con un agente alcalino para mejorar la absorcion.